2025 HD Clinical Research Congress

October 10 - 13, 2025

JW Marriott, Nashville, TN

Be part of the first-ever Huntington’s Disease Clinical Research Congress, an international gathering dedicated to advancing clinical research and care for HD.

Over three days in Nashville, you’ll engage with leading investigators, clinicians, and industry partners through in-depth presentations, panel discussions, and networking sessions designed to spark collaboration and accelerate progress.

This year’s program, developed by the Huntington Study Group, CHDI Foundation, and the European Huntington’s Disease Network, features long-form platform presentations, new data on HD biomarkers and assessments, and forward-looking conversations on clinical trial design. Together, we’re creating a new collaborative approach to HD clinical research meetings that maximizes impact and drives innovation.

Join us October 11–13, 2025, at the J.W. Marriott in Nashville, TN, and help shape the future of HD clinical research and care.

2025 Sponsors

Abstract Poster Submissions

The regular abstract submission window is now closed. Abstracts submitted during the late breaking period (July 17-31) will not be included in the Journal of Huntington’s Disease.
 
  • Accepted abstracts will be assigned poster space onsite. Authors will be notified in early August regarding acceptance for exhibition and publication.
  • Select abstracts may be invited for brief oral platform presentations at the Congress. Industry submissions are not eligible for oral presentation.
  • For questions regarding abstracts, please contact nashville2025abstracts@venuesworld.com.